Allopurinol may cut risk for neurodegenerative diseases
Xanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 in PLOS ONE.
May 19, 2023
0
4
Xanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 in PLOS ONE.
May 19, 2023
0
4
Researchers at Nagoya University in Japan have discovered a receptor, sigma-1 receptor, and a protein, ATAD3A, that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. Since there ...
Apr 26, 2023
0
2
A randomized clinical trial is looking at whether fecal microbiota transplantation (FMT) from healthy donors into adults with early-stage amyotrophic lateral sclerosis (ALS—one of the most common forms of motor neuron disease) ...
Apr 17, 2023
0
10
University of Malta researchers have discovered a potential new drug target for amyotrophic lateral sclerosis (ALS), according to a new study published in the Neurobiology of Aging journal.
Mar 14, 2023
0
3
Multisite chronic pain is causally associated with a higher risk for multiple sclerosis (MS) and rheumatoid arthritis (RA), but not with other autoimmune diseases (AIDs), according to a study published online Feb. 9 in Frontiers ...
Feb 22, 2023
0
6
Frontotemporal degeneration (FTD) is a group of neurologic disorders associated with changes in personality, behavior, language or movement. Some FTD forms are inherited, and some are not. Typically, people develop FTD symptoms ...
Feb 20, 2023
0
27
Limbic predominate age-related TDP-43 encephalopathy or LATE is a recently recognized form of dementia that affects memory, thinking and social skills. It mimics Alzheimer's disease or AD (and sometimes co-exists with it), ...
Dec 15, 2022
0
10
Oregon State University scientists have taken a key step toward better understanding neurodegenerative diseases by using a suite of biophysical techniques to learn more about a motor protein whose malfunction is associated ...
Dec 1, 2022
0
43
A number of new neurologic medications for diseases like multiple sclerosis (MS), Parkinson's disease and migraine have received U.S. Food and Drug Administration (FDA) approval over the past decade. However, with most having ...
Nov 30, 2022
0
2
Scientists at the Francis Crick Institute have found that deleting two genes that encode key enzyme proteins (kinases NDR1 and NDR2), impairs the health of neurons and leads to neurodegeneration in young mice as well as in ...
Nov 30, 2022
0
4